Treatments and therapies for cancer care have improved, but access and affordability are increasingly difficult. Guests John Hennessy of Valuate and Matt Farber of OffScrip Health explain what needs to happen next.
The good news: The cancer death rate in America has fallen 33% since 1991.
The bad news: The cost for treatment remains a huge barrier for some patients.
One recent study put the economic and human costs of cancer in adolescents and young adults at $23.5 billion overall -- nearly $260,000 per patient.
To get a sense of how to improve access and affordability, The IDI host Ira Apfel spoke to John Hennessy and Matt Farber.
Hennessy is a Principal at Valuate and a former executive director of the Kansas City Cancer Center, and former executive director the community cancer program at the University of Kansas Hospital.
Farber is the vice president for Enterprise Partnerships with OffScrip Health, one of the fastest-growing patient access, impact, and content influencers in the country.
Follow John Hennessy on LinkedIn.
Follow Matt Farber on LinkedIn.
Follow Valuate on LinkedIn or visit us at ValuateHealth.com.